» Articles » PMID: 38665556

Investigating the Effects of on H3N2-Induced Inflammatory and Immune Responses Through Network Pharmacology, Molecular Docking, and Experimental Validation in a Mice Model

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Apr 26
PMID 38665556
Authors
Affiliations
Soon will be listed here.
Abstract

For centuries, (LP), a Chinese herbal medicine, has been widely employed for treating respiratory infectious diseases; however, the mechanism underlying LP's effectiveness against the influenza A/Aichi/2/1968 virus (H3N2) remains elusive. This study aims to shed light on the mechanism by which LP combats influenza in H3N2-infected mice. First, we conducted quasi-targeted metabolomics analysis using liquid chromatography-mass spectrometry to identify LP components. Subsequently, network pharmacology, molecular docking, and simulation were conducted to screen candidate targets associated with AKT and NF-κB. In addition, we conducted a series of experiments including qPCR, hematoxylin-eosin staining, flow cytometry, immunohistochemistry, and enzyme-linked immunosorbent assay to provide evidence that LP treatment in H3N2-infected mice can reduce pro-inflammatory cytokine levels (TNF-α, IL-6, IL-1β, and MCP-1) while increasing T cells (CD3, CD4, and CD8) and syndecan-1 and secretory IgA expression. This, in turn, aids in the prevention of excessive inflammation and the fortification of immunity, both of which are compromised by H3N2. Finally, we utilized a Western blot assay to confirm that LP indeed inhibits the AKT/NF-κB signaling cascade. Thus, the efficacy of LP serves as a cornerstone in establishing a theoretical foundation for influenza treatment.

References
1.
Brauer R, Ge L, Schlesinger S, Birkland T, Huang Y, Parimon T . Syndecan-1 Attenuates Lung Injury during Influenza Infection by Potentiating c-Met Signaling to Suppress Epithelial Apoptosis. Am J Respir Crit Care Med. 2016; 194(3):333-44. PMC: 4970595. DOI: 10.1164/rccm.201509-1878OC. View

2.
Smyk J, Szydlowska N, Szulc W, Majewska A . Evolution of Influenza Viruses-Drug Resistance, Treatment Options, and Prospects. Int J Mol Sci. 2022; 23(20). PMC: 9602850. DOI: 10.3390/ijms232012244. View

3.
Jheng J, Hsieh C, Chang Y, Ho J, Tang W, Chen Z . Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3β and phosphorylated AKT expression levels. J Microbiol Immunol Infect. 2022; 55(4):598-610. DOI: 10.1016/j.jmii.2022.04.012. View

4.
Yu J, Li H, Jia J, Huang Z, Liu S, Zheng Y . Pandemic influenza A (H1N1) virus causes abortive infection of primary human T cells. Emerg Microbes Infect. 2022; 11(1):1191-1204. PMC: 9045768. DOI: 10.1080/22221751.2022.2056523. View

5.
Wu Y, Yang L, Wang F, Wu X, Zhou C, Shi S . Hepatoprotective and antioxidative effects of total phenolics from Laggera pterodonta on chemical-induced injury in primary cultured neonatal rat hepatocytes. Food Chem Toxicol. 2007; 45(8):1349-55. DOI: 10.1016/j.fct.2007.01.011. View